In Italy, vaccination against COVID-l 9 began on December 27, 2020. To date, 13,7 13,224 people in Italyare fully vaccinated, which accounts îor 25.3 oh of the general population, and 44.804 received at least onevaccination dose. Thc prescnt study aim to investigate willingness to receive COVID-I9 vaccination incostumers accessing a sample of community pharmacies in the Province of Palermo, Italy. A self-administered and anon),rnous questionnaire was carried out among costumers older than 18 ycars oldbetween Dcccmbcr 2020 atrd March 2021. Three hundred and sixty-three subjects were enrolled in thestudy, 259 (71.3%) expressed their willingness to receive COVID-19 vaccination. The main dctcrminantsassociated with vaccination acccptance resulted "trust in safety and eflectiveness ofvaccinations" and theabsence of any previous negative vaccination experience. Unfavourable information on COVID-I9vaccination obtained through intemelmedia/social media and lack ofconfidence in COVID-I9 vaccinesand in the Italian national healthcare system are the main determinants associated with vaccine refusal.Male gender, younger age classes and influenza vaccination acceptance due to the impact of COVIDpandemic were significantly associated with willingness to be vaccinated against COVID-Ì9. In order topromote COVID-I9 vaccination campaign accumte, infomrative and communicative campaigr dedicatedto subjects that are more hesitant regarding COVID-I9 vaccination (e.g. female sex, adults, people thatusually do not adhere to influenza vaccination campaign) should be implemented.
|Numero di pagine||5|
|Rivista||EuroMediterranean Biomedical Journal|
|Stato di pubblicazione||Published - 2021|
All Science Journal Classification (ASJC) codes